Report Detail
Global MicroRNA (miRNA) Market Size, Status and Forecast 2019-2025
- RnM3199562 |
- 21 May, 2020 |
- Global |
- 93 Pages |
- QYResearch |
- Other
This report covers market size and forecasts of MicroRNA (miRNA), including the following market information:
Global MicroRNA (miRNA) Market Size, 2019-2021, and 2020 (quarterly data), (US$ Million)
Global MicroRNA (miRNA) Market Size by Type and by Application, 2019-2021, and 2020 (quarterly data), (US$ Million)
Global MicroRNA (miRNA) Market Size by Region (and Key Countries), 2019-2021, and 2020 (quarterly data), (US$ Million)
Global MicroRNA (miRNA) Market Size by Company, 2019- 2020 (quarterly data), (US$ Million)
Key market players
Major competitors identified in this market include Thermofisher Scientific (Life Technologies), Agilent Technologies, Merck KGaA, QIAGEN (Exiqon), NanoString Technologies, Inc., Dharmacon (Horizon Discovery Group), Synlogic, GeneCopoeia, Inc., New England Biolabs, Quantabio, NanoString Technologies, Inc., BioGenex, SeqMatic LLC, etc.
Based on the Region:
Asia-Pacific (China, Japan, South Korea, India and ASEAN)
North America (US and Canada)
Europe (Germany, France, UK and Italy)
Rest of World (Latin America, Middle East & Africa)
Based on the Type:
Sample collection
miRNA cDNA Synthesis
Profiling & Purification
Detection
Functional Studies
Based on the Application:
Cancer
Infectious Diseases
Immunological Disorder
Cardiovascular Disease
Neurological Disease
Others
- 1.4.1 Research Process
- 1.4.2 Data Triangulation
- 1.4.3 Research Approach
- 1.4.4 Base Year
- 1.5.1 Covid-19 Impact: Global GDP Growth, 2019, 2020 and 2021 Projections
- 1.5.2 Covid-19 Impact: Commodity Prices Indices
- 1.5.3 Covid-19 Impact: Global Major Government Policy
2 Global MicroRNA (miRNA) Quarterly Market Size Analysis
- 2.1 MicroRNA (miRNA) Business Impact Assessment - COVID-19
- 2.1.1 Global MicroRNA (miRNA) Market Size, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026
- 2.2 Global MicroRNA (miRNA) Quarterly Market Size 2020-2021
- 2.3 COVID-19-Driven Market Dynamics and Factor Analysis
- 2.3.1 Drivers
- 2.3.2 Restraints
- 2.3.3 Opportunities
- 2.3.4 Challenges
3 Quarterly Competitive Assessment, 2020
- 3.1 By Players, Global MicroRNA (miRNA) Quarterly Market Size, 2019 VS 2020
- 3.2 By Players, MicroRNA (miRNA) Headquarters and Area Served
- 3.3 Date of Key Players Enter into MicroRNA (miRNA) Market
- 3.4 Key Players MicroRNA (miRNA) Product Offered
- 3.5 Mergers & Acquisitions, Expansion Plans
4 Impact of Covid-19 on MicroRNA (miRNA) Segments, By Type
- 4.1 Introduction
- 1.4.1 Sample collection
- 1.4.2 miRNA cDNA Synthesis
- 1.4.3 Profiling & Purification
- 1.4.4 Detection
- 1.4.5 Functional Studies
- 4.2 By Type, Global MicroRNA (miRNA) Market Size, 2019-2021
5 Impact of Covid-19 on MicroRNA (miRNA) Segments, By Application
- 5.1 Overview
- 5.5.1 Cancer
- 5.5.2 Infectious Diseases
- 5.5.3 Immunological Disorder
- 5.5.4 Cardiovascular Disease
- 5.5.5 Neurological Disease
- 5.5.6 Others
- 5.2 By Application, Global MicroRNA (miRNA) Market Size, 2019-2021
- 5.2.1 By Application, Global MicroRNA (miRNA) Market Size by Application, 2019-2021
6 Geographic Analysis
- 6.1 Introduction
- 6.2 North America
- 6.2.1 Macroeconomic Indicators of US
- 6.2.2 US
- 6.2.3 Canada
- 6.3 Europe
- 6.3.1 Macroeconomic Indicators of Europe
- 6.3.2 Germany
- 6.3.3 France
- 6.3.4 UK
- 6.3.5 Italy
- 6.4 Asia-Pacific
- 6.4.1 Macroeconomic Indicators of Asia-Pacific
- 6.4.2 China
- 6.4.3 Japan
- 6.4.4 South Korea
- 6.4.5 India
- 6.4.6 ASEAN
- 6.5 Rest of World
- 6.5.1 Latin America
- 6.5.2 Middle East and Africa
7 Company Profiles
- 7.1 Thermofisher Scientific (Life Technologies)
- 7.1.1 Thermofisher Scientific (Life Technologies) Business Overview
- 7.1.2 Thermofisher Scientific (Life Technologies) MicroRNA (miRNA) Quarterly Revenue, 2020
- 7.1.3 Thermofisher Scientific (Life Technologies) MicroRNA (miRNA) Product Introduction
- 7.1.4 Thermofisher Scientific (Life Technologies) Response to COVID-19 and Related Developments
- 7.2 Agilent Technologies
- 7.2.1 Agilent Technologies Business Overview
- 7.2.2 Agilent Technologies MicroRNA (miRNA) Quarterly Revenue, 2020
- 7.2.3 Agilent Technologies MicroRNA (miRNA) Product Introduction
- 7.2.4 Agilent Technologies Response to COVID-19 and Related Developments
- 7.3 Merck KGaA
- 7.3.1 Merck KGaA Business Overview
- 7.3.2 Merck KGaA MicroRNA (miRNA) Quarterly Revenue, 2020
- 7.3.3 Merck KGaA MicroRNA (miRNA) Product Introduction
- 7.3.4 Merck KGaA Response to COVID-19 and Related Developments
- 7.4 QIAGEN (Exiqon)
- 7.4.1 QIAGEN (Exiqon) Business Overview
- 7.4.2 QIAGEN (Exiqon) MicroRNA (miRNA) Quarterly Revenue, 2020
- 7.4.3 QIAGEN (Exiqon) MicroRNA (miRNA) Product Introduction
- 7.4.4 QIAGEN (Exiqon) Response to COVID-19 and Related Developments
- 7.5 NanoString Technologies, Inc.
- 7.5.1 NanoString Technologies, Inc. Business Overview
- 7.5.2 NanoString Technologies, Inc. MicroRNA (miRNA) Quarterly Revenue, 2020
- 7.5.3 NanoString Technologies, Inc. MicroRNA (miRNA) Product Introduction
- 7.5.4 NanoString Technologies, Inc. Response to COVID-19 and Related Developments
- 7.6 Dharmacon (Horizon Discovery Group)
- 7.6.1 Dharmacon (Horizon Discovery Group) Business Overview
- 7.6.2 Dharmacon (Horizon Discovery Group) MicroRNA (miRNA) Quarterly Revenue, 2020
- 7.6.3 Dharmacon (Horizon Discovery Group) MicroRNA (miRNA) Product Introduction
- 7.6.4 Dharmacon (Horizon Discovery Group) Response to COVID-19 and Related Developments
- 7.7 Synlogic
- 7.7.1 Synlogic Business Overview
- 7.7.2 Synlogic MicroRNA (miRNA) Quarterly Revenue, 2020
- 7.7.3 Synlogic MicroRNA (miRNA) Product Introduction
- 7.7.4 Synlogic Response to COVID-19 and Related Developments
- 7.8 GeneCopoeia, Inc.
- 7.8.1 GeneCopoeia, Inc. Business Overview
- 7.8.2 GeneCopoeia, Inc. MicroRNA (miRNA) Quarterly Revenue, 2020
- 7.8.3 GeneCopoeia, Inc. MicroRNA (miRNA) Product Introduction
- 7.8.4 GeneCopoeia, Inc. Response to COVID-19 and Related Developments
- 7.9 New England Biolabs
- 7.9.1 New England Biolabs Business Overview
- 7.9.2 New England Biolabs MicroRNA (miRNA) Quarterly Revenue, 2020
- 7.9.3 New England Biolabs MicroRNA (miRNA) Product Introduction
- 7.9.4 New England Biolabs Response to COVID-19 and Related Developments
- 7.10 Quantabio
- 7.10.1 Quantabio Business Overview
- 7.10.2 Quantabio MicroRNA (miRNA) Quarterly Revenue, 2020
- 7.10.3 Quantabio MicroRNA (miRNA) Product Introduction
- 7.10.4 Quantabio Response to COVID-19 and Related Developments
- 7.11 NanoString Technologies, Inc.
- 7.11.1 NanoString Technologies, Inc. Business Overview
- 7.11.2 NanoString Technologies, Inc. MicroRNA (miRNA) Quarterly Revenue, 2020
- 7.11.3 NanoString Technologies, Inc. MicroRNA (miRNA) Product Introduction
- 7.11.4 NanoString Technologies, Inc. Response to COVID-19 and Related Developments
- 7.12 BioGenex
- 7.12.1 BioGenex Business Overview
- 7.12.2 BioGenex MicroRNA (miRNA) Quarterly Revenue, 2020
- 7.12.3 BioGenex MicroRNA (miRNA) Product Introduction
- 7.12.4 BioGenex Response to COVID-19 and Related Developments
- 7.13 SeqMatic LLC
- 7.13.1 SeqMatic LLC Business Overview
- 7.13.2 SeqMatic LLC MicroRNA (miRNA) Quarterly Revenue, 2020
- 7.13.3 SeqMatic LLC MicroRNA (miRNA) Product Introduction
- 7.13.4 SeqMatic LLC Response to COVID-19 and Related Developments
8 Key Findings
9 Appendix
- 9.1 About US
Summary:
Get latest Market Research Reports on MicroRNA (miRNA) . Industry analysis & Market Report on MicroRNA (miRNA) is a syndicated market report, published as Global MicroRNA (miRNA) Market Size, Status and Forecast 2019-2025. It is complete Research Study and Industry Analysis of MicroRNA (miRNA) market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
